Greenwich LifeSciences In...

AI Score

0

Unlock

11.70
-0.52 (-4.26%)
At close: Mar 03, 2025, 3:59 PM
11.70
0.00%
After-hours: Mar 03, 2025, 04:00 PM EST

Greenwich LifeSciences Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -15.2 -25.79 -69.32 -248.8 -17.14 -35.42 -37.32
PEG Ratio -0.9 -0.38 -0.52 5.15 -0.16 -4.6 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 20.17 14.85 11.74 16.77 -43.48 -5.91 -6.88
P/FCF Ratio -20.86 -31.66 -73.38 -401.83 -200.22 -520.66 -485.89
P/OCF Ratio -20.86 -31.66 -73.38 -401.83 -200.22 -520.66 -485.89
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio n/a n/a n/a 0.00 -0.00 -0.04 n/a
Quick Ratio 23.74 51.23 70.63 27.41 0.00 0.12 0.00
Current Ratio 23.74 51.23 70.63 27.41 0.00 0.12 0.00
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -1.33 -0.58 -0.17 -0.07 2.54 0.17 0.18
Return on Assets (ROA) -1.27 -0.56 -0.17 -0.06 -128.43 -15.57 -58.05
Return on Capital (ROIC) -1.39 -0.61 -0.17 -0.07 2.54 2.73 2.97
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a